Table 1

The input values for clinical options for breast cancer detection derived from a literature search

Proposed Diagnostic Tests/Assays
SN
SP
Cost($)
Reference
PMID

Magnetic Resonance Imaging (MRI)
0.96
0.75
100.00
Imbriaco et al. 2001 [11]
11202453
Electrical Impedance Scanning
0.38
0.95
100.00
Stojadinovic et al., 2006 [12]
16491309
electronic resonance spectroscopy of albumin configuration
0.85
0.91
100.00
Seidel et al., 2005 [13]
16422355
SCM Test
0.81
0.85
100.00
Klein et al., 2002 [14]
14965713
Serum TSGF
0.6386
0.9089
100.00
Liang et al., 2002 [15]
12526228
mammaglobin (cutpoint 8.8)
0.688
0.888
100.00
Bernstein et al., 2005 [16]
16166429
SELDI (serum), CART, two surfaces
0.9
0.93
100.00
Vlahou et al., 2003 [17]
14499014
scintimammography on px w/suspicious breast mass
0.9
0.938
100.00
Polan et al., 2001 [18]
11353112
NAS bFGF, race, menopausal status + PSA
0.909
0.833
100.00
Hsiung et al., 2002 [19]
12184408
cytology alone, breast ductal lavage cells
0.67
0.93
100.00
Zhang et al., 2006 [20]
16477639
G-actin biomarker, breast ductal lavage cells
0.9
1
100.00
Zhang et al., 2006 [20]
16477639
DNA5cER biomarker, breast ductal lavage cells
1
0.93
100.00
Zhang et al., 2006 [20]
16477639

Shi and Lyons-Weiler BMC Medical Informatics and Decision Making 2007 7:23   doi:10.1186/1472-6947-7-23